XENE
58.45 USD
+2.35%
Today
-0.80%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Xenon Pharmaceuticals Inc Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
5.42B
Avg Daily Volume
1.31M
52 Week High
63.95 USD
52 Week Low
26.74 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In addition, the company's Phase 1 Single Ascending Dose/Multiple Ascending Dose products include XEN1701 targeting the sodium channel and XEN1120 targeting the Kv7 potassium channel for the treatment of pain. The company has a license and collaboration agreement with Neurocrine Biosciences, Inc. for the development of NBI-921355, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Top News
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
tradingview.com
3d ago
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
tradingview.com
0mo ago
Apollo
-2.49%
AresManagement
-4.10%
AeroVironment
+1.88%
BookingHld
-1.76%
Blackstone
-1.66%
Coeur
+2.59%
CFIndustries
+1.73%
Campbell_Soup
-1.73%
Corteva
+0.43%
Precision.Bio
+1.86%
EOG.Inc
-0.39%
Expand.Energy
-0.46%
Expedia
-1.01%
Diamondback
+0.88%
Fair_Isaac
-13.78%
HyattHotels
-0.35%
Hecla.Mining
+0.73%
Kala.Pharma
+12.50%
KKR&Co
-1.65%
Kosmos
+0.79%
Mosaic
-2.06%
Nebius.Group
+6.52%
NIKE
-3.01%
RealtyIncome
+0.93%
OracleCorp
+0.02%
Occidental
+0.00%
Pacira
-0.84%
PapaJohns
+0.91%
Schlumberg
-1.10%
UberTech
-1.74%
Valero
+1.57%
Viatris
-0.88%
Xenon_Pharma
-0.80%
BUZZ-U.S. STOCKS ON THE MOVE-Agricultural stocks, Papa John's, Oil companies
reuters.com
1mo ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
